LH Labcorp Holdings Inc.
USHealthcareAs of 2026-07-09 16:00
Why LH matters now
Labcorp Holdings Inc. (LH) is a US stock in Healthcare. The latest InvestLog snapshot shows $277.63 with -0.04% on the session and $22.77B in market capitalization; recent performance reads 1-month +0.84% and YTD +1.97%.
The latest financial table shown here is Q1 2026, with revenue of $3.54B, net income of $277.8M, and EPS of $3.35. Investors can compare that operating picture with valuation signals such as P/E 24.68 and FCF yield 6.6%.
The latest indexable market news headline is "Labcorp Declares Quarterly Dividend" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $300.00; recent insider activity includes Kyle Kathryn W filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
24.68
PEG
1.41
P/B
2.41
P/S
1.48
EV/EBITDA
13.20
DCF Value
$389.36
FCF Yield
6.6%
Div Yield
1.1%
Margins & Returns
Gross Margin
27.8%
Operating Margin
11.0%
Net Margin
6.7%
ROE
10.9%
ROA
4.9%
ROIC
7.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $3.54B | $277.8M | $3.35 |
| Q4 2025 | $3.52B | $164.7M | $1.98 |
| FY 2025 | $13.95B | $876.5M | $10.46 |
| Q3 2025 | $3.56B | $261.1M | $3.12 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$311.33
Target (Median)
$300.00
Target Range
$300.00 - $334.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
0.88
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.